New investigational drug for patients with Large B-cell Lymphoma

Trial ID:
IRB-24-8456
Anuj Mahindra, MD

Inclusion Criteria

Patients must:

  • Be 18-80 years old
    Be previously untreated with CD20-positive LBCL.
    Be able to provide a tumor tissue sample
    Have a negative SARS-CoV2 antigen or PCR test

Exclusion Criteria

Patients must not:

  • Have any prior therapy for the disease
    Have prior solid organ transplantation
    Have a history of any other cancer malignancy
    Have any recent major surgery
    Be pregnant or breastfeeding

Additional Info

All treatments and physician visits during this study will take place at Scripps Clinic Torrey Pines (Geisel Pavilion).

For more information search NCT06047080 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org